×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TEVA – teva pharmaceutical industries limited american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TEVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
02:28 pm
teva
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding [Yahoo! Finance]
Low
Report
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding [Yahoo! Finance]
3/4
02:23 pm
teva
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today [Yahoo! Finance]
Low
Report
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today [Yahoo! Finance]
3/4
12:18 pm
teva
Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026 [Yahoo! Finance]
Low
Report
Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026 [Yahoo! Finance]
3/4
08:44 am
teva
Teva Pharmaceutical Industries (TEVA) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $41.00 price target on the stock, up from $40.00.
Low
Report
Teva Pharmaceutical Industries (TEVA) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $41.00 price target on the stock, up from $40.00.
3/3
10:11 pm
teva
????????:???????????????????2035????354.1??????? [CNET News]
Low
Report
????????:???????????????????2035????354.1??????? [CNET News]
3/3
05:26 pm
teva
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug [Yahoo! Finance]
Low
Report
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug [Yahoo! Finance]
3/3
05:00 pm
teva
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Low
Report
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
3/2
03:32 pm
teva
The Best Healthcare Stock to Invest $1,000 in Right Now [Yahoo! Finance]
Low
Report
The Best Healthcare Stock to Invest $1,000 in Right Now [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
1/28/2026
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
4.4%
teva pharmaceutical industries limited american depositary shares
11/5/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
9.9%
teva pharmaceutical industries limited american depositary shares
7/30/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
0.4%
teva pharmaceutical industries limited american depositary shares
5/7/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
5.3%
teva pharmaceutical industries limited american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/5
05:49 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Shields Matthew
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Shields Matthew
3/5
05:44 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Jover Placid
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Jover Placid
3/5
05:39 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Savage Brian
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Savage Brian
3/5
05:32 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Fox Christine
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Fox Christine
3/5
05:26 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Francis Richard D
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Francis Richard D
3/5
05:13 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Hughes Eric A
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Hughes Eric A
3/5
05:09 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Daniell Richard
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Daniell Richard
3/5
04:12 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 03 Filed by: Weiss Amir
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 03 Filed by: Weiss Amir
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/18
Shortage of critical children’s cancer drug causes concerns nationwide [MSNBC.com]
16.9%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
TOP News Decliners
5/11
U.S. states sue Teva, 19 other drug companies in price-fixing complaint [Reuters (UK)]
-14.7%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: